News

Federal Court of Justice invalidates SPC for Gilead blockbuster drug Truvada

In Germany, the Federal Court of Justice invalidates Gilead’s Truvada SPC as most other Courts in Europe considering the CJEU’s Teva ruling C-121/17—a step towards harmonisation of EU law on SPCs.

26/09/2020 | Dr. Günter Isenbruck

Congratulations to our Partners Ulrike Herr and Fritz Lahrtz!

Further news articles

03/01/2024

The article EPA – Lösungsmittel – Neuheit einer nicht medizinischen Verwendung“ by our partner Dr Markus Jacobi has been published in IP kompakt, December 2023 issue.

Read article

13/10/2022

VPP Vortragsveranstaltung der Bezirksgruppe Mitte-Süd

Read article

02/08/2022

Sustainability award granted to the patent law firm Isenbruck Bösl Hörschler

Read article

01/01/2022

Dr. Ivo Ruttekolk becomes Salary Partner

Read article

Contact

Call us or write to us.
We will be happy to advise you.

Phone

+49 621 42 271-0 (Mannheim)

+49 211 157756-0 (Düsseldorf)

info-man@ib-patent.de